A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. [electronic resource]
- The Journal of antimicrobial chemotherapy Jun 2000
- 843-9 p. digital
Adult Anti-Bacterial Agents--therapeutic use Body Temperature Double-Blind Method Female Fever--drug therapy Gram-Positive Bacterial Infections--drug therapy Humans Imipenem--therapeutic use Male Methicillin Resistance Middle Aged Neutropenia--drug therapy Prospective Studies Recurrence Teicoplanin--therapeutic use Thienamycins--therapeutic use Treatment Outcome